胆木浸膏片通过促进SIRT3介导的SOD2去乙酰化改善牙周炎
该研究探讨胆木浸膏片(DMJGT)抗牙周炎机制,采用UPLC-Q-TOF-MS分析成分,分子对接、MD模拟和SPR预测SIRT3结合,并在结扎诱导牙周炎小鼠和LPS刺激RAW264.7细胞中验证。结果表明DMJGT通过上调SIRT3增强SOD2去乙酰化,抑制氧化应激和M1极化,促进M2极化,减轻牙槽骨丢失,且SIRT3抑制剂或siRNA可逆转效应。
要点
- DMJGT减轻小鼠牙周炎牙槽骨丢失和炎症。
- DMJGT上调SIRT3,增强SOD2去乙酰化,改善线粒体功能。
- DMJGT抑制M1、促进M2极化,SIRT3抑制或敲低可逆转。
核心结论
- DMJGT通过上调SIRT3表达并增强SIRT3介导的SOD2去乙酰化通路,减轻氧化应激、维持线粒体功能并促使巨噬细胞向抗炎表型极化,从而缓解牙周炎。
研究设计与样本
- 研究采用UPLC-Q-TOF-MS分析DMJGT成分,结合分子对接、MD模拟和SPR预测化合物与SIRT3结合。
- 在结扎诱导牙周炎小鼠中,用Micro-CT和染色评估牙槽骨丢失与组织病理。
- 在LPS刺激的RAW264.7巨噬细胞中检测ROS、线粒体功能、氧化应激标志物、蛋白和mRNA水平。
- 通过体内3-TYP抑制和体外Sirt3 siRNA敲低确认SIRT3依赖性。
主要发现
- DMJGT减少牙槽骨丢失、破骨细胞和炎症。
- DMJGT上调SIRT3、TFAM和PGC-1α,降低Ac-SOD2(K68),恢复氧化还原标志物。
- DMJGT抑制M1并促进M2极化,减少细胞因子;3-TYP或Sirt3 siRNA可逆转这些效应。
临床怎么用
- DMJGT可能通过SIRT3-SOD2通路调节巨噬细胞极化,为牙周炎治疗提供机制依据。
- SIRT3是DMJGT抗牙周炎的关键靶点,提示其临床应用中可关注SIRT3相关通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Nauclea officinalis (Pierre ex Pit.) Merr. & Chun is a traditional medicinal plant widely used by the Li ethnic group in Hainan Province, China. Danmu Jingao Tablet (DMJGT), a Chinese patent medicine derived from this plant, exhibits well-documented anti-inflammatory and antioxidant activities. Periodontitis is a chronic inflammatory disease characterized by progressive alveolar bone resorption, in which macrophage oxidative stress and M1 polarization are key drivers. However, whether DMJGT exerts its anti-periodontitis effects through regulating macrophage polarization remains unclear. AIM OF THE STUDY: This study aimed to investigate whether DMJGT ameliorates periodontitis by upregulating SIRT3 expression and enhancing the SIRT3-mediated SOD2 deacetylation pathway, thereby suppressing macrophage oxidative stress, preserving mitochondrial function, and modulating macrophage polarization. MATERIALS AND METHODS: DMJGT constituents were analyzed by UPLC-Q-TOF-MS, with molecular docking, MD simulations, and SPR predicting compound-SIRT3 binding. In ligature-induced periodontitis mice, alveolar bone loss and histopathology were evaluated by Micro-CT and staining. In LPS-stimulated RAW264.7 macrophages, ROS, mitochondrial function, oxidative stress markers, protein levels (SIRT3, SOD2, Ac-SOD2, TFAM, PGC-1α, CD86, CD206), and mRNA (Sirt3, Il1b, Il6, Tnf) were assessed. SIRT3 dependency was confirmed by 3-TYP inhibition in vivo and siRNA knockdown in vitro. RESULTS: Eighty-three compounds were identified, with strictosamide, vincosamide, and naucleofficine A showing high binding affinity to SIRT3. DMJGT reduced alveolar bone loss, osteoclasts, and inflammation. It upregulated SIRT3, TFAM, and PGC-1α, decreased Ac-SOD2 (K68), restored redox markers, suppressed M1 and promoted M2 polarization, and reduced cytokines. 3-TYP or Sirt3 siRNA reversed these effects. CONCLUSIONS: DMJGT alleviates periodontitis by upregulating SIRT3 expression and enhancing the SIRT3-mediated SOD2 deacetylation pathway. This pathway reduces oxidative stress, preserves mitochondrial function, and reprograms macrophage polarization toward an anti-inflammatory phenotype. SIRT3 is a critical target for DMJGT, providing a new mechanistic basis for its clinical application in periodontitis.
引用
- Liu H, Wang Y, Yu Y, et al. Danmu Jingao Tablet attenuates periodontitis by promoting SIRT3-mediated SOD2 deacetylation and mitochondrial redox homeostasis. J Ethnopharmacol. 2026. PMID: 42906800. doi:10.1016/j.jep.2026.122552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。